ALT vs XOM · rev $5.0K vs P/E 24, rev $201.16B
Altimmune Inc (ALT) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported ALT revenue for 2025-09-30 was $5.0K. Net income was -$60.7M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ALT currently screens at market cap $527.0M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
ALT currently screens at market cap $527.0M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the ALT and XOM stock pages for the full models.
Not investment advice.